AARDEX Group

AARDEX Group is invited as a guest speaker at the 2019 ASCPT

ascpt
Bernard Vrijens, CEO of AARDEX Group, is invited as a guest speaker at the 2019

Bernard Vrijens, CEO of AARDEX Group, is invited as a guest speaker at the 2019 ANNUAL MEETING of the American Society for Clinical Pharmacology and Therapeutics (ASCPT), Washington, March 13-16, 2019.

During the session ” Implementing Adherence Programs in Drug Development and Post Approval Settings” follow is intervention “Insights From Monitoring Adherence in Clinical Trials and in Clinical Care: Understanding the Key Question of Drug Forgiveness” 

Visit the website at: https://www.ascpt.org/Meetings/Annual-Meeting

Share This Post

You may also like...

Breaking News

Is Neglecting Medication Adherence in Neurology Drug Trials Putting Patients at Risk?

The list of Neurological conditions is considerable, with epilepsy, Alzheimer’s disease, dementia, stroke, migraine, multiple sclerosis, Parkinson’s disease, neuro infections, and brain tumors, all attributed to this category of disease. Hundreds of millions of people worldwide are affected by neurological

Bias in clinical Research
Breaking News

Unmasking Bias in Clinical Research: A Historical Perspective

It’s an uncomfortable truth that decision-making is a murky business. While we would all like to think that our actions and the choices underpinning them are rooted in logic, integrity, and reason, the truth is not entirely clear-cut. In reality,